CA
CGON icon

Cliff Asness’s CG Oncology CGON Stock Holding History

Cliff Asness’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.28M Sell
102,397
-11,945
-10% -$781K ﹤0.01% 1767
2026
Q1 		$7.74M Buy
114,342
+1,993
+2% +$113K ﹤0.01% 1474
2025
Q4 		$4.66M Buy
112,349
+76
+0.1% +$3.15K ﹤0.01% 1602
2025
Q3 		$4.52M Sell
112,273
-759
-0.7% -$22.1K ﹤0.01% 1516
2025
Q2 		$2.94M Buy
113,032
+93,651
+483% +$2.26M ﹤0.01% 1572
2025
Q1 		$475K Buy
+19,381
New +$545K ﹤0.01% 2456

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cliff Asness's CGON Position: Q2 2026 in Review

Cliff Asness reduced its CG Oncology (CGON) stake by 10% in Q2 2026, selling an estimated $781K and leaving 102,397 shares worth $7.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1767.

Cliff Asness first reported a position in CGON in Q1 2025 and has held it in 6 quarters since. The position peaked at $7.74M in Q1 2026. 226 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Cliff Asness held 102,397 shares of CG Oncology worth $7.28M as of Q2 2026.
  • Cliff Asness sold 11,945 CG Oncology shares in Q2 2026, an estimated $781K.
  • CG Oncology made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #1767 holding.
  • Cliff Asness first reported a position in CG Oncology in Q1 2025 and has held it in 6 quarters since.
  • Cliff Asness's CG Oncology position peaked at $7.74M in Q1 2026.
  • 226 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.